Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001274173-22-000082
Filing Date
2022-02-14
Accepted
2022-02-14 08:20:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 JANUS HENDERSON GROUP PLC OWNS 5.7% OF ALIGOS CIK 0001799448 algs2102022.txt SC 13G 8869
  Complete submission text file 0001274173-22-000082.txt   10591
Mailing Address 201 BISHOPSGATE LONDON X0 EC2M 3AE
Business Address 201 BISHOPSGATE LONDON X0 EC2M 3AE 442078181818
JANUS HENDERSON GROUP PLC (Filed by) CIK: 0001274173 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Subject) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91770 | Film No.: 22625509
SIC: 2836 Biological Products, (No Diagnostic Substances)